Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study)

ConclusionsThe results suggest that week 12 Hb levels  ≥ 11 g/dL achieved with C.E.R.A. treatment were associated with better renal outcomes than Hb levels <  11 g/dL.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research